Takafumi Yanagisawa
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 273 publications
Diet and risk of bladder cancer: a systematic review of epidemiological evidence.
Journal: BJU international
Published: August 24, 2026
Timing-dependent skin toxicity phenotypes during enfortumab vedotin plus pembrolizumab therapy for advanced urothelial carcinoma.
Journal: International journal of clinical oncology
Published: June 04, 2026
Enfortumab vedotin plus pembrolizumab for recurrent metastatic urothelial carcinoma following adjuvant nivolumab.
Journal: Japanese journal of clinical oncology
Published: May 25, 2026
First-Line Systemic Treatments of Metastatic Hormone-Sensitive Prostate Cancer: Updated Systematic Review and Network Meta-Analysis.
Journal: The Journal of urology
Published: May 22, 2026
Impact of Surgical Techniques on Anastomotic Stricture in Urinary Diversion: A Systematic Review and Meta-analysis.
Journal: European urology open science
Published: May 01, 2026
From Genes to Proteins: The Indispensable Role of Proteogenomics in Advancing Clear Cell Renal Cell Carcinoma Research.
Journal: International journal of molecular sciences
Published: April 12, 2026
Differential impact of host-related factors on survival outcomes between IO+IO and IO+TKI in metastatic renal cell carcinoma: a multicenter retrospective study.
Journal: International journal of clinical oncology
Published: April 11, 2026
Development of a Prognostic Model for Patients Aged ≤65 Years With Metastatic Renal Cell Carcinoma.
Journal: Anticancer research
Published: April 02, 2026
Efficacy and safety of first-line immune checkpoint inhibitor-based combination therapy in metastatic renal cell carcinoma patients on hemodialysis.
Journal: Urologic oncology
Published: April 02, 2026
Real-world safety and effectiveness of enfortumab vedotin plus pembrolizumab in locally advanced or metastatic urothelial carcinoma: A multicenter Japanese cohort study.
Journal: Urologic oncology
Published: March 30, 2026
Development of a prognostic model for elderly patients with metastatic clear cell renal cell carcinoma treated with first-line immuno-oncology combination therapy.
Journal: Japanese journal of clinical oncology
Published: March 16, 2026
Last Updated: 09/26/2026